Join leading scientists, clinicians, industry innovators, and translational researchers on March 16-17, 2027 to explore the rapidly evolving field of vaccines for chronic disease.
Vaccines have traditionally been used as the most effective medical interventions to reduce the death and morbidity caused by infectious diseases. Recently, chronic diseases are emerging as an important public health problem with serious human, social, and economic burden. With the growing burden of chronic diseases and the limited availability of curative treatments, it is crucial to explore innovative approaches in vaccine and immunotherapy design for preventing, delaying, and treating a wide range of chronic diseases such as Alzheimer’s disease, Parkinson’s disease, cancer, multiple sclerosis, chronic hepatitis B infection, HIV, HPV-associated diseases, and other major global health challenges.
The program will explore the growing role of vaccines across neurodegenerative disease, cancer, autoimmune disorders, and chronic infectious diseases, while also examining future opportunities in areas such as obesity and addiction. Together, these discussions will provide a comprehensive view of how vaccines are being reimagined to address some of the most pressing and complex diseases of our time.